- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Big Pharma Weighs Role in ACOs
Pharmaceuticals companies continue to weigh options for their role in Accountable Care Organizations (ACOs).
Pharmaceuticals companies continue to weigh options for their role in Accountable Care Organizations (ACOs). As with other collaborators, they are deliberating ways they can best reduce costs and improve quality. MedCity News reports:
Like Will Rogers, Dr. David Nash is reluctant to predict the future. But when prodded, the dean of Jefferson’s School of Population Health described a post Accountable Care Act world in which pharmaceutical options will be dictated by outcomes and value. Pharmaceutical companies are trying to figure out the best way they can reduce costs and generate revenue.
“We’re going to see more emphasis on the cost effectiveness and cost benefit of products. Clearly any provider organization that’s going at economic risk…will care a lot more in 2015, 2016 about the economics of the pharma products they are using..We are in need of better population based data.”
The panel discussion at the CONVERGE conference in Philadelphia this week highlighted some interesting ways pharmaceutical companies can respond to these needs by Accountable Care Organizations and what else they can do to add value.
Read the full story: http://bit.ly/14KUjrI
Unlocking Access: Exploring Mental Health Care Among Medicaid Managed Care Enrollees
January 23rd 2025On this episode of Managed Care Cast, we speak with the author of a study published in the January 2025 issue of The American Journal of Managed Care® to examine the association between quantitative network adequacy standards and mental health care access among adult Medicaid enrollees.
Listen
Balancing Innovation and Equity in Oncology Value-Based Care: Panel Discussions
January 27th 2025Discussions also delved into the complexities of value-based oncology care, the growing role of real-world data, and strategies to improve access to care in hematology. Across all sessions, a common theme emerged: the need to balance innovation with patient-centered, equitable, and sustainable care models.
Read More
Executive Orders Suggest Swift Pivot in Managed Care and Health Policy
January 22nd 2025President Donald Trump's initial executive orders target previous efforts to reduce health care costs, pandemic preparedness, and international partnerships, showing a stark contrast to the Biden administration.
Read More
